These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. The use of physostigmine in diphenhydramine overdose. Padilla RB; Pollack ML Am J Emerg Med; 2002 Oct; 20(6):569-70. PubMed ID: 12369036 [No Abstract] [Full Text] [Related]
44. Best evidence topic report. Gammahydroxybutyrate overdose and physostigmine. Allen L; Alsalim W Emerg Med J; 2006 Apr; 23(4):300-1. PubMed ID: 16549578 [No Abstract] [Full Text] [Related]
45. [Thorn apple poisoning]. de Vries I; Meulenbelt J Ned Tijdschr Geneeskd; 1997 Jul; 141(29):1446-7. PubMed ID: 9542875 [No Abstract] [Full Text] [Related]
46. Physostigmine for Antimuscarinic Toxicity. Saadi R; Bohnenberger K J Emerg Nurs; 2020 Jan; 46(1):126-128. PubMed ID: 31918808 [No Abstract] [Full Text] [Related]
47. [Aminostigmine-a novel drug against home poisoning]. Bonitenko II; Safronov GA; Sosiukin AE; Pershin VN; Shpilenia LS Klin Med (Mosk); 1996; 74(8):58-61. PubMed ID: 9036214 [TBL] [Abstract][Full Text] [Related]
48. Adverse events from physostigmine: An observational study. Nguyen TT; Armengol C; Wilhoite G; Cumpston KL; Wills BK Am J Emerg Med; 2018 Jan; 36(1):141-142. PubMed ID: 28716594 [No Abstract] [Full Text] [Related]
49. Microbial transformation of N-heptyl physostigmine, a semisynthetic alkaloid inhibitor of cholinesterase. So L; White R; Arison B; Petuch B; Schwartz MS; Cheng H; Monaghan R; Chen TS J Ind Microbiol; 1995 Aug; 15(2):108-11. PubMed ID: 7576461 [TBL] [Abstract][Full Text] [Related]
50. Physostigmine as treatment for severe CNS anticholinergic toxicity. Teoh R; Page AV; Hardern R Emerg Med J; 2001 Sep; 18(5):412. PubMed ID: 11559630 [No Abstract] [Full Text] [Related]
51. [Effect of diazepam on antidote therapy of lethal toxic effects of soman in rats]. Kassa J Ceska Slov Farm; 2001 Sep; 50(5):254-7. PubMed ID: 11579693 [TBL] [Abstract][Full Text] [Related]
56. Pharmacologic cholinesterase inhibition improves survival in experimental sepsis. Hofer S; Eisenbach C; Lukic IK; Schneider L; Bode K; Brueckmann M; Mautner S; Wente MN; Encke J; Werner J; Dalpke AH; Stremmel W; Nawroth PP; Martin E; Krammer PH; Bierhaus A; Weigand MA Crit Care Med; 2008 Feb; 36(2):404-8. PubMed ID: 18091537 [TBL] [Abstract][Full Text] [Related]
57. The cholinesterase inhibitor physostigmine for the local treatment of dry mouth: a randomized study. Khosravani N; Birkhed D; Ekström J Eur J Oral Sci; 2009 Jun; 117(3):209-17. PubMed ID: 19583746 [TBL] [Abstract][Full Text] [Related]
58. [Drugs for Alzheimer disease: what will the minister decide]. Verhey FR; Scheltens P Tijdschr Gerontol Geriatr; 1998 Dec; 29(6):278-9. PubMed ID: 9894324 [No Abstract] [Full Text] [Related]
59. Protracted post-traumatic confusional state treated with physostigmine. Eames P; Sutton A Brain Inj; 1995 Oct; 9(7):729-34. PubMed ID: 8680399 [TBL] [Abstract][Full Text] [Related]
60. Physostigmine, a highly potent antidote for acute experimental diazepam intoxication. Nagy J; Decsi L Neuropharmacology; 1978 Jul; 17(7):469-75. PubMed ID: 692813 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]